Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK), and Pharmacodynamics (PD) of Liposomal siRNA in Subjects With High Cholesterol
Clinical trial NCT00927459 · TERMINATED
Trial details
- NCT number
- NCT00927459
- Sponsor
- Arbutus Biopharma Corporation
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2009-06-01
- Primary completion
- 2009-12-01
- Enrollment
- 23
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.